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Abstract Since the 1990s, the International Union of
Immunological Societies (IUIS) PID expert committee (EC),
now called Inborn Errors of Immunity Committee, has pub-
lished every other year a classification of the inborn errors of
immunity. This complete catalog serves as a reference for im-
munologists and researchers worldwide. However, it was un-
adapted for clinicians at the bedside. For those, the IUIS PID
EC is now publishing a phenotypical classification since 2013,
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which proved to be more user-friendly. There are now 320
single-gene inborn errors of immunity underlying phenotypes
as diverse as infection, malignancy, allergy, auto-immunity, and
auto-inflammation. We herein propose the revised 2017 pheno-
typic classification, based on the accompanying 2017 IUIS
Inborn Errors of Immunity Committee classification.
Keywords Primary immunodeficiencies . Classification .
Phenotypic . IUIS . Inborn errors of immunity
Human primary immunodeficiency diseases (PID) comprise
330 distinct disorders with 320 different gene defects listed
[1]. Long considered as rare diseases, recent studies tend to
show that they are more common than generally thought, if
only by their rapidly increasing number [2, 3].The
International Union of Immunological Societies (IUIS) PID
expert committee proposed a PID classification since 1999
[1], which facilitates clinical research and comparative studies
worldwide; it is updated every other year to include new dis-
orders or disease-causing genes. This classification is orga-
nized in tables, each of which groups PIDs that share a given
pathogenesis. As this catalog is not adapted for use by the clini-
cian at the bedside, the now called Inborn Errors of Immunity
Committee proposed since 2013 a phenotypic complement to its
classification [4]. Moreover, a smartphone application has been
published, based on the 2015 phenotypic classification [5]. As
the number of inborn errors of immunity is quickly increasing,
and at an even faster pace since the advent of next-generation
sequencing, this phenotypic classification requires revision at
the same pace as the classical IUIS classification.
Here, we present an update of these figures (Figs. 1, 2,
3, 4, 5, 6, 7, 8, and 9), based on the accompanying 2017
report in inborn errors of immunity. We included all dis-
eases included in the 2017 update of the IUIS classifica-
tion [1] and split some categories in two parts to ease the
lecture. An algorithm was assigned to each of the nine
main groups of the classification and the same color was
used for each group of similar conditions. Disease names
are presented in red and genes in bold and italics. Mode
of inheritance is expressed when adequate; if not
expressed, the default mode of transmission is autosomal
recessive. Clinical features that point to several diseases
are presented in italics before the disease names.
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Fig. 1 Immunodeficiencies affecting cellular and humoral immunity. a
Severe combined immunodeficiencies defined by T cell lymphopenia. b
Combined immunodeficiencies. * T cell lymphopenia in SCID is defined
by CD3+ Tcells < 300/µL. AD: autosomal dominant transmission; ADA:
adenosine deaminase; Ag: antigen; AR: autosomal recessive
transmission; β2m: bêta-2 microglobulin; Bc: B cells; CBC: complete
blood count; CD: cluster of differentiation; CVID: common variable
immunodeficiency; def: deficiency; EBV: Epstein Barr virus; HHV8:
human herpes virus 8; HIGM: hyper IgM syndrome; HPV: human
papillomavirus; Ig: immunoglobulins; MHC: major histocompatibility
complex; Nl: normal; NK: natural killer; SCID: severe combined
immunodeficiency; Tc: T cells; TCR: T cell receptor; Treg: regulatory T
cells; XL: X-linked transmission
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CD19 NL : SCID T- B+
SCID T-B+NK-
AR,
CD 132+
JAK-3 def.
JAK3
ADA def . ADA
Chondrosternal
dysplasia,
deafness, may have
pulmonary alveolar
proteinosis, cognive
defects
Recular dysgenesis.
AK2
Granulocytopenia,
Thrombocytopenia
deafness.
CD19 ↓ : SCID T-B-
SCID T-B-NK-
- With facial
dysmorphism:
DNA ligase IV def .
LIG4
CERNUNNOS /XLF
def. NHEJ1.
Radiaon
sensive
- Without facial
dysmorphism:
DNA PKcs def.
PRKDC
Radiosensibility
RAG 1/2 def.
(RAG1/
RAG2)
DCLRE1C def.
DCLRE1C
(ARTEMIS).
Radiosensibi-
lity
SCID T-B-NK+SCID T-B+NK+
IL7R .
IL7R
XL,
CD 132-
c deﬁciency.
IL2RG
Coronin-1A
def . CORO1A
Detectable
thymus
Yes No
Microcephaly ?
Nl γ/δ T cells :
CD45 def.
PTPRC
I. Immunodeﬁciencies aﬀecng cellular and humoral immunity.
(a) Severe combined immunodeﬁciencies SCID, deﬁned by CD3 T cell lymphopenia*.
No γ/δ T cells:
CD3δ. CD3D
CD3ε. CD3E
CD3ζ . CD247
Winged helix
def. FOXN1.
Severe
infecons;
abnormal
thymic
epithelium;
congenital
alopecia, nail
dystrophy,
neural tube
defect.
Ig Low
CD40 ligand def. (CD154). XL, CD40LG. or CD40
def. AR, CD40. Opportunisc infecons, biliary
tract and liver disease, Cryptosporidium. HIGM.
Neutropenia, thrombocytopenia, hemolyc
anemia, IgM normal or high, other Ig isotypes
low. Bc: sIgM+, IgD+ cells present, absent sIgG+,
IgA+ and IgE+ cells. Tc: NL to low.
Low CD8
Nl MHC I on lymphocytes.
ZAP-70 def. ZAP70 May have immune
dysregulaon, autoimmunity. Nl Ig. CD4: Low
foncon
CD3γ def. CD3G TCR low.
Low CD4:
MHCII Expression ?
Absent :
MHC-II def.
RFXANK,CIITA,
RFX5, RFXAP
Diarrhea,
respiratory
infecons,
liver/biliary tract
disease
Present:
XL MAGT1 def.
MAGT1.
AR, LCK def. LCK.
Immune dysregulaon,
autoimmunity. Low
Treg, restricted T cell
repertoire, poor TCR
signaling;
AD :UNC119 def.
UNC119
DOCK8 def. DOCK8.Severe
Eczema. Cutaneous viral
and staphylococcal
infecons; severe atopy;
cancer ,diathesis. High IgE,
Low IgM, eosinophilia. Low
NK with poor funcon. Low
CD27+ memory Bc Poor
peripheral Bc tolerance.
MST1 def .
STK4.Intermient
neutropenia; bacterial, viral
(HPV), candidal infecons;
EBV lymphoproliferaon;
autoimmune cytopenias;
lymphoma; congenital heart
disease. Low T and B. High
Ig. Low terminal
diﬀerenated eﬀector
memory cells, low naïve Tc,
poor proliferaon.
RHOH def. RHOH. HPV
infecon, lung granulomas,
molluscum contagiosum,
lymphoma. Low naïve T
cells, restricted repertoire,
poor proliferaon to CD3.
TCRα def .TRAC.
Recurrent viral, bacterial,
fungal infecons; immune
dysregulaon and
autoimmunity; diarrhea.
Absent TCRαβ; all Tc are γδ;
poor proliferaon.
IL21R def . IL21R. Recurrent
infecons;
Pneumocyss, Cryptosporidium.
Tc: low cytokine
producon; poor angen
proliferaon.
CARD11 deﬁciency (LOF). CARD1. Pneumocyss
jirovecii pneumonia, bacterial & viral infecons
.Ig:Absent/low.Tc:NL number, poor proliferaon
OX40 def. OX40.
Kaposi’s sarcoma, impaired
immunity to HHV8. Low
memory Bc. Tc : low Ag
speciﬁc memory CD4+.
IKBKB def. IKBKB. Recurrent bacterial, viral and
fungal infecons. Opportunisc infecons. Bc :
poor foncons. absent Treg and γδ T cells;
impaired TCR acvaon.
DOCK2 def. DOCK2. Low Tc; NL NK but defecve
funcon. Poor interferon responses in
hematopoiec and non-hematopoiec cells. IgG
NL or low; poor anbody responses.
ICOS def. ICOS. Autoimmunity, gastroenteris,
granulomas (CVID).
IL21 def. IL21. Severe early
onset colis. Low IgG. Tc :
NL / low funcon.
NIK def. MAP3K14.
Bacterial, viral and
Cryptosporidium infecons.
Low NK and Ig levels. Low
switched memory Bc. Tc :Ag
poor proliferaon
Absent MHC I on lymphocytes.
MHC-I def .
TAP2, TAP1 or TAPBP
Vasculis, pyoderma gangrenosum. Nl Ig.
B2M
Sinopulmonary infecons, cutaneous granulomas.
Nl Ig. Hypoprodemia. Absent β2m associated
proteins MHC-I, CD1a, CD1b, CD1c.
MALT1 def. MALT1. Bacterial,
fungal and viral infecons.
Impaired Tc proliferaon and
anbody response
BCL10 def. BCL10. Recurrent bacterial and viral
infecons, candidiasis, gastroenteris. Low
memory T and Treg cells, poor Ag and an-CD3
prolif. Decreased memory and switched Bc
I. Immunodeﬁciencies aﬀecng cellular and humoral immunity
(b) Combined Immunodeﬁciencies Generally Less Profound than Severe Combined Immunodeﬁciency
Moesin def. MSN. XL,
Recurrent infecons with
bacteria, varicella;
neutropenia. Low Ig over
me. Tc: defecve
migraon, proliferaon.
CD8 def . CD8A
Maybe asymptomac. CD8 Absent.
BCL11B deﬁciency.
BCL11B. AD. Congenital
abnormalies: neonatal
teeth, dysmorphic facies;
absent corpus callosum;
neurocognive deﬁcits. Tc :
Low, poor proliferaon. TFRC deﬁciency. TFRC. Neutropenia,
thrombocytopenia. Bc:Nl number, low memory
Bc. Tc: Nl number, poor proliferaon .
RelB deﬁciency.RELB.Tc:poor diversity, poor
funcon
Low Bc: Ig : o
en NL
LAT def . LAT.
Adenopathy,
splenomegaly,
autoimmunity. High Ig .
T and B : NL to low
Normal Ig but Poor
Speciﬁc Anbody
response
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Ataxia telangiectasia. ATM: Ataxia; telangiectasia; pulmonary infecons; lymphorecular and other malignancies; increased α-
fetoprotein; increased radiosensivity, chromosomal instability and translocaons. O	en decreased IgA, IgE and IgG subclasses; increased
IgM; anbodies variably decreased. Tc : Progressive decrease, abnormal proliferaon to Mitogens.
IIa. CID with associated or syndromic features
Carlage Hair Hypoplasia.
RMRP.Short-limbed dwarﬁsm
with metaphyseal dysostosis,
sparse hair, bone marrow
failure; autoimmunity;
suscepbility to lymphoma
and other cancers; impaired
spermatogenesis; neuronal
dysplasia of the intesne. Ig:
Normal or reduced. Tc: Varies
from severely decreased
(SCID) to normal; impaired
lymphocyte proliferaon.
Schimke sd. SMARCAL1
Short stature, spondylo-
epiphyseal dysplasia, IUGR;
nephropathy; bacterial, viral,
fungal infecons; may
present as SCID; bone
marrow failure. Tc:
Decreased.
Thymic
Defects with
Addional
Congenital
Anomalies
Congenital thrombocytopenia
Bloom sd. BLM.Short stature; bird like face; sun-sensive erythema; marrow failure; leukemia; lymphoma; chromosomal instability. Low Ig.
PMS2 def. PMS2. Café-au-lait spots ; lymphoma, colorectal carcinoma, brain tumors. HIGM and abnormal anbody responses. Reduced
Bc, switched and non-switched.
Immunodeﬁciency with centromeric instabily and facial anomalies. ICF1. DNMT3B; ICF2:ZBTB24; ICF3:CDCA7; ICF4:HELLS.Facial
dysmorphism; macroglossia; bacterial/opportunisc infecons; malabsorpon; malignancies. Cytopenias; mulradial conﬁguraons of
chromosomes 1,9,16; no DNA breaks. Ig: Hypogammaglobulinemia; Tc and Bc: decreased or Nl.
RNF168 def. RNF168. Short stature; mild defect of motor control to ataxia; normal intelligence to learning diﬃcules; mild facial
dysmorphism to microcephaly; increased radiosensivity ( = Riddle Sd). Low IgG or IgA.
DNA Repair Defects other than those listed in Table1:  Karyotype
XL: Wisko Aldrich Sd . WAS (LOF). XL thrombocytopenia is a mild form of WAS. Recurrent bacterial and viral infecons; bloody
diarrhea; eczema; lymphoma; autoimmune disease; IgA nephropathy; vasculis. Small platelets; Decreased IgM. Low anbody to
polysaccharides; o	en increased IgA and IgE. Nl Bc. Tc: Progressive decrease in numbers; Low Tc responses to an-CD3.
AR: WIP deﬁciency. WIPF1, Recurrent bacterial and viral infecons; eczema; bloody diarrhea . WAS protein absent. +/- small
platelets; increased IgE. Bc : Nl to low. Tc: Reduced; defecve lymphocyte responses to an-CD3.
AR: ARPC1B deﬁciency. ARPC1B. Recurrent invasive infecons, colis, vasculis. Mild thrombocytopenia, normal sized platelets;
autoanbodies (ANA, ANCA); eosinophilia; defecve Arp2/3, ﬁlament branching. High IgA and IgE.
AD. Hypoparathyroidism,
conotruncal cardiac
malformaon, velopalatal
insuﬃciency, facial
dysmorphism, intellectual
disability . Ig : Normal or
decreased. Tc: Decreased or
Nl :
DiGeorge/velocardiofacial
Sd. Chr22q11.2 deleon Sd.
22q11.2DS.
TBX1 deﬁciency . TBX1
+ Renal disease, deafness.
Chromosome 10p13-p14
deleon Syndrome.
10p13-p14DS.
MCM4 def. MCM4. Viral infecons:EBV,HSV,VZV.Short stature.Bc lymphoma; Adrenal failure; NKc low number and funcon.
AD. CHARGE sd. CHD7,
SEMA3E.
Coloboma, heart anomaly,
choanal atresia, intellectual
disability, genital and ear
anomalies; CNS
malformaon; some are SCID-
like and have low TRECs. Ig:
Normal or decreased. Tc:
Decreased or normal;
response to PHA may be
decreased
POLE1 (Polymerase ε subunit 1) deﬁciency . POLE1.Recurrent respiratory infecons; meningis; facial dysmorphism, livido, short stature
(FILS syndrome). Low IgM, lack of anbody to PPS. Low memory Bc. Decreased Tc proliferaon.
POLE2 (Polymerase ε subunit 2) deﬁciency. POLE2. Recurrent infecon, systemic BCG infecons, autoimmunity (type 1 diabetes,
hypothyroidism), facial dysmorphism; Low Ig; Very low Bc. Lymphopenia, lack of TRECS, absent proliferaon of angens.
Ligase I deﬁciency . LIGI Recurrent respiratory infecons; growth retardaon; sun sensivity; lymphoma; radiaon sensivity. Low IgA and
IgG. Reduced anbody responses. Lymphopenia, decreased mitogen response.
Nijmegen breakage sd. NBS1. Microcephaly; bird-like face; lymphomas; solid tumors; increased radiosensivity; chromosomal instability.
O	en decreased IgA, IgE and IgG subclasses;increased IgM; anbodies variably decreased. Bc: Variably reduced. Tc: progressive decrease.
NSMCE3 deﬁciency. NSMCE3. Severe lung disease (possibly viral); thymic hypoplasia, Chromosomal breakage; radiaon sensivity. Ig:
Decreased Ab responses to PPS, normal IgG, IgA, elevated IgM. Tc : Number decreased, poor response to mitogens and angens.
ERCC6L2 (Hebo deﬁciency). ERCC6L2. Facial dysmorphism; microcephaly, bone marrow failure. Low Bc, Nl Ig. Lymphopenia.
MYSM1 deﬁciency. MYSM1.
Short stature, congenital bone
marrow failure,
myelodysplasia, Skeletal
anomalies; cataracts;
developmental delay. Aﬀects
granulocytes. Bc: immature.
Tc: lymphopenia, reduced
naïve Tc.
Hypogammaglobulinemia.
MOPD1 Deﬁciency. RNU4ATAC.Recurrent bacterial infecons,
lymphadenopathy, Spondyloepiphyseal dysplasia, IUGR, renal
dystrophy, facial dysmorphism; +/- microcephaly. Ig: NL speciﬁc
anbodies variably decreased.
Immuno-
osseous
dysplasias
GINS1 def. GINS1. IUGR. Neutropenia, NK cells very low. Tc: and Bc low or normal. High IgA, Low IgG and IgM.
EXTL3 Deﬁciency. EXTL3. Platyspondyly, kyphosis, variable skeletal
dysplasias, developmental delay Ig: variably decreased. Tc: reduced.
Fig. 2 a, b CID with associated or syndromic features. Ab: antibody;
AD: autosomal dominant transmission; ANA: anti-nuclear antibodies;
ANCA: anti-neutrophil cytoplasm antibodies; AR: autosomal recessive
transmission; Bc: B cells; BCG: Bacillus Calmette-Guerin; BCR: B cell
receptor; CD: cluster of differentiation; CMV: cytomegalovirus; CNS:
central nervous system; def: deficiency; DNA: desoxyribonucleic acid;
DKC: dyskeratosis congenita; EDA: anhidrotic ectodermal dysplasia;
GOF: gain-of-function; HIES: hyper IgE syndrome; FILS: facial
dysmorphism, immunodeficiency, livedo and short stature; ID:
immunodeficiency; Ig: immunoglobulins; IUGR: intrauterine growth
retardation; LOF: loss-of-function; MDS: myelodysplasia; Nl: normal;
NK: natural killer; PHA: phytohemagglutinin; PPS: polysaccharides;
SCID: severe combined immunodeficiency; sd: syndrome; Tc: T cells;
TCR: Tcell receptor; TREC: Tcell receptor excision circle; XL: X-linked
transmission
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Dyskeratosis congenita.
IUGR, microcephaly, nail dystrophy, sparse scalp
hair and eyelashes; poikiloderma or abnormal skin
pigmentaon; palmar hyperkeratosis;
premalignant oral leukoplakia; pancytopenia; +/-
recurrent infecons. A severe phenotype with
developmental delay and cerebellar hypoplasia
known as Hoyeraal-Hreidarsson Syndrome (HHS)
may occur in some paents. Ig and Bc: variable.
DKC1: XL, Bc and Tc: Progressive decrease.
NOLA2 (NHP2), NOLA3 (NOP10): AR, Tc:
Decreased. RTEL1 : AD/AR, Tc: Decreased. TERC,
TINF2: AD,Tc: variable. TERT, TPP1: AD/AR, Tc:
variable. DCLRE1B/ SNM1/APOLLO, PARN,
WRAP53: AR,Tc: variable.
Dyskeratosis congenita (DKC)
Myelodysplasia, defecve
telomere maintenance
Exclude other causes: Fanconi anemia,
Blackfan-Diamond
Others
IIb. CID with associated or syndromic features
COATS plus Sd. Intracranial calciﬁcaon, abnormal
telomeres, IUGR, gastrointesnal hemorrhage due
to vascular ectasia, hypocellular bone marrow.
pancytopenia
STN1: premature aging,
CTC1 : sparse graying hair, dystrophic nails,
osteopenia, renal telangiectasia
Hyper-IgE
syndromes (HIES)
AD-HIES (Job sd). STAT3, LOF.
Disncve facial features (broad
nasal bridge); bacterial infecons
(boils and pulmonary abscesses,
pneumatoceles) due to S. aureus,
Aspergillus, Pneumocyss jirovecii;
eczema; mucocutaneous candidiasis;
hyperextensible joints, osteoporosis
and bone fractures, scoliosis,
retenon of primary teeth;
aneurysm formaon Ig:Elevated IgE;
speciﬁc anbody producon
decreased. Bc:Normal; reduced
switched and non-switched memory
Bc; BAFF expression increased. Tc:Nl
overall; Th-17 and T-follicular helper
cells decreased.
Comel Netherton sd. SPINK5;
Congenital ichthyosis, bamboo
hair;,atopic diathesis; increased
bacterial infecons. Elevated IgE and
IgA; Other Ig: variably decreased.
Bc: Switched and non-switched Bc
are reduced.
PGM3 deﬁciency. PGM3. Severe
atopy; autoimmunity; Immuno-
osseous dysplasias. Recurrent
pneumonia, recurrent skin
abscesses,bacterial and viral
infecons; cognive impairment;
hypomyelinaon. Ig:Nl or elevated.
Elevated IgE; eosinophilia. Reduced
B and memory Bc. CD8 and CD4 Tc
may be decreased.
SAMD9. AD. SAMD9 (GOF) : IUGR with gonadal
abnormalies, adrenal failure, MDS with
chromosome 7 aberraons, predisposion to
infecons, enteropathy, absent spleen
SAMD9L. AD. SAMD9L. (GOF) :Cytopenia,
predisposion to MDS with chromosome 7
aberraons and progressive cerebellar
dysfuncon
Megaloblasc anemia, Ig:
decreased.
Transcobalamin 2
deﬁciency. TCN2.
pancytopenia, if
untreated for prolonged
periods results in
intellectual disability.
Deﬁciency causing
hereditary folate
malabsorbon. SLC46A1.
if untreated for prolonged
periods results in
intellectual disability
Methylene-
tetrahydrofolate
dehydrogenase 1
deﬁciency.
MTHFD1.Recurrent
bacterial infecon,
Pneumocyss jirovecii,
neutropenia, seizures,
intellectual disability,
folate-responsive, poor
anbody responses to
conjugated
polysaccharide angens.
Low Bc.
Anhidroc ectodermal
dysplasia,various infecons
(bacteria, mycobacteria, viruses
and fungi), colis, variable
defects of skin, hair and teeth.
NEMO deﬁciency. IKBKG
(NEMO). XL, monocyte
dysfuncon. Ig decreased,
some with elevated IgA, IgM,
poor speciﬁc anbody
responses, absent anbody to
polysaccharide angens. Bc: Nl,
Low memory and isotype
switched Bc. Tc: Nl/decreased,
TCR acvaon impaired.
EDA-ID due to IKBA GOF
mutaon. NFKBIA (IKBA). AD
Tc and monocyte dysfuncon
Decreased IgG and IgA,
elevated IgM, poor speciﬁc
anbody responses, absent
anbody to polysaccharide
angens. Normal Bc numbers,
impaired BCR acvaon, low
memory and isotype switched
Bc. Normal total Tc, TCR
acvaon impaired.
Purine nucleoside phosphorylase
deﬁciency. PNP. Autoimmune hemolyc
anemia, neurological impairment.
Hypouricemia. Ig : Nl/Low. Bc: Nl. Tc:
Progressive decrease
ID with mulple intesnal atresias.
TTC7A . Bacterial (sepsis), fungal, viral
infecons, mulple intesnal atresias, o	en
with intrauterine polyhydramnios and early
demise, some with SCID phenotype.
Markedly decreased IgG, IgM, IgA.
Bc:Nl/low.Tc: Variable/absent,low TRECs.
Hepac veno-occlusive disease with
immunodeﬁciency (VODI). SP110.
Hepac veno-occlusive disease,
Pneumocyss jirovecii pneumonia, CMV,
candida, thrombocytopenia,
hepatosplenomegaly, cerebrospinal
leukodystrophy. Decreased IgG, IgA, IgM,
absent germinal centers and ssue
plasma cells. Decreased memory Bc .
Decreased memory Tc.
Vici syndrome. EPG5. Agenesis of the
corpus callosum, cataracts,
cardiomyopathy,skin hypopigmentaon,
intellectual disability, microcephaly,
CMC. Ig: Decreased IgG2. Bc: Defecve.
Profound depleon of CD4+ cells.
Defects of Vitamin
B12 and Folate
Metabolism:
Anhidroc
Ectodermodysplasia
with ID
Bacterial infecons, autoinﬂammaon, amylopecnosis.Bc: Nl,decreased memory Bc.
HOIL1 deﬁciency. HOIL1 (RBCK1). Poor anbody responses to polysaccharides.
HOIP deﬁciency. HOIP1 (RNF31). Lymphangiectasia. Ig: decreased.
Calcium Channel Defects. Autoimmunity, EDA, non-progressive myopathy. Ig and Bc: Nl. Tc: Normal,
defecve TCR mediated acvaon. ORAI-1 deﬁciency. ORAI1 . STIM1 deﬁciency. STIM1
Hennekam-lymphangiectasia-lymphedema syndrome. CCBE1. Lymphangiectasia and lymphedema with facial abnormalies and other dysmorphic features. Ig: decreased. Bc and Tc: Variable.
STAT5b deﬁciency. STAT5B. Growth-hormone insensive dwarﬁsm, dysmorphic features, eczema, lymphocyc intersal pneumonis, autoimmunity.
Kabuki Sd. Typical facial abnormalies, cle	 or high arched palate, skeletal abnormalies, short stature, intellectual disability, congenital heart defects, recurrent infecons (os media, pneumonia) in 50% of
paents. Autoimmunity may be present. Low IgA and occasionally low IgG. KMT2D (MLL2): AD. KDM6A: XL.
Fig. 2 (continued)
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IgG, IgA and/or IgM
Exclude second causes: drugs [Hx], myeloma [bone marrow], lymphoma. Ig loss (not hypo-IgM) in urine, gastro-intestinal or skin.
→ B Lymphocyte (CD19+) enumeration (CMF)
B >1 %B absent 
Severe bacterial infection. All Ig isotypes
decreased.
X-Linked Agammaglobulinemia. BTK. 
Some patients have detectable Ig. ProBc: 
Nl
AR : μ heavy chain Def. IGHM
Igα def. CD79A,      Igβ def. CD79B
BLNK def. BLNK,   λ5 def. IGLL1
ProBc: Nl
PI3KR1 def. PIK3R1. ProBc: Decreased
AD
E47 transcription factor def. TCF3.
CVID with no gene defect speciﬁed.
Clinical phenotypes vary: most have recurrent infecons, some
have polyclonal lymphoproliferaon, autoimmune cytopenias
and/or granulomatous disease
III. Predominantly Antibody deficiencies, a: Hypogammaglobulinemia
Serum Immunoglobulin Assays : IgG, IgA, IgM, IgE
Commun Variable Immunodeficiency Phenotype
AD. Severe bacterial infecons; EBV suscepbility.
PIK3CD mutaon (GOF). PIK3CD GOF. Decreased pro-Bc.
PIK3R1 deﬁciency (LOF). PIK3CD. Pro-BcpresentandlowmemoryBc.
PTEN Deﬁciency (LOF). PTEN. AD. Lymphoproliferaon,
Autoimmunity.
TACI deﬁciency. TNFRSF13B (TACI). AD or AR . Variable clinical expression
CD20 deﬁciency. CD20.Recurrent infecons. Low
IgG, Nl or elevated IgM and IgA.
CD81 deﬁciency. CD81. Recurrent infecons, may have glomerulonephris.
CD19 deﬁciency. CD19. Recurrent infecons,
may have glomerulonephris.
CD21 deﬁciency. Recurrent infecons. Low IgG,
impaired an-pneumococcal response.
BAFF receptor deﬁciency. TNFRSF13C (BAFF-R). Variable clinical expression. Low IgG and IgM.
Mannosyl-oligosaccharide glucosidase deﬁciency (MOGS). MOGS (GCS1). Bacterial and viral infecons, severe
neurologic disease, also known as congenital disorder of glycosylaon type IIb (CDG-IIb). Severe hypogammagl.
TWEAK deﬁciency. TWEAK (TNFSF12). AD. Pneumonia, bacterial infecons, warts, thrombocytopenia.
Neutropenia. Low IgM and A, lack of an-pneumococcal anbody.
TTC37 deﬁciency. TTC37 . Recurrent bacterial and viral infecons, Abnormal hair ﬁndings: trichorrhexis nodosa.
Poor anbody response to pneumococcal vaccine.
TRNT1 deﬁciency. TRNT1. Congenital
sideroblasc anemia, deafness, developmental
delay. B cell deﬁciency and hypogammagl.
NFKB1 deﬁciency. NFKB1. AD. Recurrent
sinopulmonary infecons, COPD, EBV
proliferaon, autoimmunity, autoinﬂammaon.
Ig normal or low, Bc low or normal, low memory
Bc.
NFKB2 deﬁciency. NFKB2. AD. Recurrent
sinopulmonary infecons, alopecia and
endocrinopathies (ie, central adrenal
insuﬃciency). Low Bc.
IRF2BP2 deﬁciency. IRF2BP2. Recurrent infecons, possible autoimmunity and inﬂammatory disease.
Hypogammaglobulenia, absent IgA.
IKAROS deﬁciency. IKZF1. AD. Recurrent
sinopulmonary infecons. Low or normal Bc
potenally reducing levels with age.
ATP6AP1 deﬁciency. ATP6AP1. XL.
Hepatopathy, leukopenia, low copper.
Leukopenia and hypogammagl.
III. Predominantly Antibody deficiencies. b: Other Anbody deﬁciencies
Serum Immunoglobulin Assays : IgG, IgA, IgM, IgE
Severe Reducon in Serum IgG and IgA with
Nl/elevated IgM and Normal Numbers of Bc :
Hyper IgM Syndromes
AID deﬁciency. AICDA.
Bacterial infecons, enlarged lymph nodes and germinal
centers.
UNG deﬁciency. UNG.
Enlarged lymph nodes and germinal centers.
INO80. INO80 .
Severe bacterial infecons.
MSH6. MSH6 .
Family or personal history of cancer. Variable IgG,
defects, increased IgM in some, Nl Bc, low switched
memory Bc.
Isotype, Light Chain, or Funconal Deﬁciencies
with Generally Nl Numbers of Bc
Ig heavy chain mutaons and deleons.
Mutaon or chromosomal deleon at 14q32.
May be asymptomac. One or more IgG and/or IgA subclasses as
well as IgE may be absent.
Kappa chain deﬁciency. IGKC.
Asymptomac. All immunoglobulins have lambda light chain.
Isolated IgG subclass deﬁciency. Unknown.
Usually asymptomac, a minority may have poor anbody
response to speciﬁc angens and recurrent viral/bacterial
infecons. Reducon in one or more IgG subclass.
IgG subclass deﬁciency with IgA deﬁciency. Unknown.
Recurrent bacterial infecons. Reduced IgA with decrease in one
or more IgG subclass.
Selecve IgA deﬁciency. Unknown.
Bacterial infecons, autoimmunity mildly increased. Very low to
absent IgA with other isotypes normal, normal subclasses and
speciﬁc anbodies.
Speciﬁc anbody deﬁciency with normal Ig levels and normal B
cells. Unknown.
Reduced ability to produce anbodies to speciﬁc angens. Ig: Nl.
Transient hypogammaglobuliemia of infancy. Unknown.
Usually not associated with signiﬁcant infecons, normal ability
to produce anbodies to vaccine angens. IgG and IgA decreased.
CARD11 GOF .
CARD11. AD. BENTA syndrome
Splenomegaly,
lymphadenopathy,
poor vaccine responses.
Selecve IgM deﬁciency. Unknown. Pneumococcal / bacterial
infecons. Absent serum IgM.
High Bc numbers due to
constuve NF-κB acvaon
Compliance with Ethical Standards
Fig. 4 Diseases of immune dysregulation. a Hemophagocytic
lymphohistiocytosis. b Other diseases of immune dysregulation. Ab:
antibody; AD: autosomal dominant transmission; Ag: antigen; ALPS:
autoimmune lymphoproliferative syndrome; APS: autoimmune
polyendocrinopathy syndrome; AR: autosomal recessive transmission; Bc:
B cells; CD: cluster of differentiation; CMF: flow cytometry; CTL: cytotoxic
T lymphocytes; def: deficiency; DNT: double negative Tcells; EBV: Epstein
Barr virus; FHL: familial hemophagocytic lymphohistiocytosis; GOF: gain-
of-function; HLH: hemophagocytic lymphohistiocytosis; (H)SM:
(hepato)splenomegalia; IBD: inflammatory bowel disease; Ig: immunoglob-
ulin; IL-10: interleukin-10; LOF: loss-of-function; iNKT: invariant NKT
cells; NK: natural killer cells; Nl: normal; sd: syndrome; SLE: systemic lupus
erythematous disease; Tc: T cells; TCR: T cell receptor; XL: X-linked
transmission
Fig. 3 Predominantly antibody deficiencies. a Hypogammaglobulinemias.
b Other antibody deficiencies. AD: autosomal dominant transmission; AR:
autosomal recessive transmission;Bc:B cells; BENTA:B cell expansionwith
NF-κB and T cell anergy; CD: cluster of differentiation; CMF: flow cytom-
etry; COPD: chronic obstructive pulmonary disease; def: deficiency; EBV:
Epstein Barr virus; GOF: gain-of-function; Hx: patient history; Ig: immuno-
globulins; Nl: normal; XL: X-linked transmission
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Perforin deﬁciency (FHL2).PRF1.
Familial Hemophagocyc
Lymphohisocytosis Syndromes: Fever,
(H)SM, cytopenias,
Nl Bc. Increased acvated Tc.
Decreased to absent NK and CTL acvies
cytotoxicity.
IV. Diseases of immune dysregulaon.
a : Hemophagocyc Lymphohisocytosis HLH & EBV suscepbility
Chediak Higashi sd. LYST
Recurrent infecons, fever, (H)SM, bleeding
tendency, progressive neurological
dysfuncon. Giant lysosomes (WBC),
neutropenia, cytopenias, Speciﬁc hair sha	
anomaly.
Griscelli sd type 2. RAB27a.
Fever, (H)SM, cytopenias; Speciﬁc hair sha	
anomaly.
Hermansky Pudlak sd type 2. AP3B1.
Recurrent infecons, pulmonary ﬁbrosis,
increased bleeding, neutropenia; Speciﬁc hair
sha	 anomaly.
Hypopigmentaon:
Paral albinism . Decreased NK and CTL
acvies(cytotoxicity and/or degranulaon). Bc and
Tc: Nl
Hermansky-Pudlak sd, type 10. AP3D1.
Oculocutaneous albinism, severe neutropenia,
recurrent infecons, seizures, hearing loss and
neurodevelopmental delay .
UNC13D / Munc13-4 deﬁciency (FHL3).
UNC13D.
STXBP2 / Munc18-2 deﬁciency (FHL5) STXBP2.
Enteropathy
Syntaxin 11 deﬁciency (FHL4). STX11.
FAAP24 deﬁciency. FAAP24.
EBV-driven lymphoproliferave
disease. Failure to kill autologous
EBV transformed Bc.
Hemophagocyc Lymphohisocytosis (HLH)
XL, XLP2. XIAP.
Splenomegaly, lymphoproliferaon,
Colis, IBD, hepas. Hypogamma-
globulinemia, Low iNKT cells.
Increased T cells suscepbility to
apoptosis to CD95 and enhanced
acvaon-induced cell death
(AICD). Normal NK and CTL
cytotoxic acvity. XIAP def (CMF)
XL, XLP1. SH2DIA.
Clinical and immunologic features
triggered by EBV infecon:
lymphoproliferaon, Lymphoma.
Hypogamma globulinemia,
Absent iNKT cells. Impaired NK
cell and CTL cytotoxic acvity .
Reduced Memory B cells . SAP
deﬁciency (CMF).
EBV associated HLH
AR, CD27 deﬁciency . CD27
(TNFRSF7).
Features triggered by EBV
infecon, aplasc anemia, low
iNKTc lymphoma. Low Ig
Suscepbility to EBV
CTPS1 deﬁciency. CTPS1.
Recurrent/chronic bacterial and viral
infecons (EBV, VZV), EBV lympho-
proliferaon, Bc non-Hodgkin
lymphoma. Tc: poor proliferaon to Ag
RASGRP1 deﬁciency. RASGRP1.
Recurrent pneumonia, herpes virus
infecons, EBV associated lymphoma.
Increased IgA. Bc and Tc: Poor
acvaon, proliferaon, molity
RLTPR (CARMIL2) deﬁciency. RLTPR. Recurrent bacterial, fungal and
mycobacterial infecons, viral warts, molluscum and EBV
lymphoproliferave and other malignancy, atopy. Ig Nl to low, poor T
dependent anbody response. Nl Bc. Tc: low Treg, high CD4, poor funcon.
CD70 deﬁciency. CD70 (TNFSF7).
Hodgkin’s lymphoma. Reduced IgM,
IgG, IgA (75%) and reduced Ag-speciﬁc
Ab responses (50%). Bc:poor anbody
and memory responses. Tc:low Treg,
poor acvaon and funcon
MAGT1 deﬁciency (XMEN). MAGT1.XL. EBV infecon, lymphoma,
viral infecons, respiratory and GI infecons. Low CD4 Low recent
thymic emigrant cells, poor proliferaon to CD3
ITK deﬁciency. ITK . EBV associated Bc lymphoproliferaon,
lymphoma, Nl or low IgG. Tc: Progressive decrease
PRKCD deﬁciency. PRKCD. Recurrent infecons, EBV
chronic infecon, lymphoproliferaon, SLE-like
autoimmunity (nephroc and anphospholipid Sd). Low
IgG. Low memory Bc high CD5 Bc
Fig. 4 (continued)
Fig. 5 Congenital defects of phagocyte number, function, or both. a
Neutropenia. b Functional defects of phagocytes. AD: autosomal
dominant transmission; AML: acute myeloid leukemia; AR: autosomal
recessive transmission; BCG: Bacillus Calmette-Guerin; CD: cluster of
differentiation; CGD: chronic granulomatous disease; CMF: flow cytom-
etry; CMML: chronic myelomonocytic leukemia; def: deficiency; DHR:
dihydrorhodamine-1,2,3; GOF: gain-of-function; IUGR: intrauterine
growth retardation; MDS: myelodysplasia; NBT: nitroblue of tetrazoli-
um; NK: natural killer cells; WBC: white blood cells; XL: X-linked
transmission
>
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IV. Diseases of immune dysregulaon. b: Sd with Autoimmunity and Others
Syndromes with Autoimmunity
Increased CD4-CD8-TCR α/β (double negative (DN) T cells) ?
ALPS 
Autoimmune
Lymphoproliferative Sd
Chronic adenopathy
Splenomegaly, defective 
lymphocyte apoptosis.
ALPS-FAS. TNFRSF6. AD or
AR. Autoimmune cytopenias,
increased lymphoma risk, IgG
and IgA Nl or increased,
elevated serum FasL, IL-10,
vitamin B12.
ALPS-Caspase 8. CASP8. AR.
Bacterial and viral infecons,
Hypogammaglobulinemia.
Defecve lymphocyte
acvaon. Slightly increased
DNT cells.
ALPS-FASLG. TNFSF6.AR.
autoimmune cytopenias, SLE,
soluble FasL is not elevated
ALPS-Caspase10. CASP10.
AD.
FADD deﬁciency. FADD. AR.
Funconal hyposplenism,
bacterial and viral infecons,
recurrent episodes of
encephalopathy and liver
dysfuncon.
No: Regulatory T Cell Defects ?
Autoimmune polyendocrinopathy with
candidiasis and ectodermal dystrophy:
APECED (APS-1) . AIRE. AR/ AD.
Hypoparathyroidism hypothyroidism,
adrenal insuﬃciency, diabetes, gonadal
dysfuncon and other endocrine
abnormalies, chronic mucocutaneous
candidiasis, dental enamel hypoplasia,
alopecia, enteropathy, pernicious anemia.
JAK1 GOF. JAK1. AD GOF. HSM, eosinophilia,
eosinophilic enteris, thyroid disease, poor
growth, viral infecons.
ZAP-70 combined hypomorphic and
acvaon mutaons. ZAP70. AR (LOF/GOF)
Severe autoimmunity. Hyperacve Zap70
kinase. Decreased CD8.
ITCH deﬁciency. ITCH. AR. Early-onset chronic
lung disease (intersal pneumonis),
thyroidis, type I diabetes, chronic
diarrhea/enteropathy,hepas, developmental
delay, dysmorphic facial features .
Tripepdyl-Pepdase II Deﬁciency. TPP2. AR.
Variable lymphoproliferaon, severe autoimmune
cytopenias, hypergammaglobulinemia, recurrent
infecons. Decreased Tc and Bc.
IPEX, immune dysregulaon,
polyendocrinopathy,
enteropathy X-linked. FOXP3.
Autoimmune enteropathy, early
onset diabetes, thyroidis
hemolyc anemia,
thrombocytopenia, eczema,
elevated IgE, IgA. Lack and/or
impaired funcon of CD4+ CD25+
FOXP3+ regulatory T cells
(Tregs).
CTLA4 deﬁciency (ALPSV). CTLA4.
AD. Autoimmune cytopenias,
enteropathy, intersal lung
disease, extra-lymphoid
lymphocyc inﬁltraon recurrent
infecons . Impaired funcon of
Tregs. Tc and Bc decreased.
CD25 deﬁciency. IL2RA. AR.
Lymphoproliferaon,
autoimmunity, impaired Tc
proliferaon. No CD4+C25+ cells
with impaired funcon of Tregs
cells.
STAT3 GOF mutaon.
STAT3. AD.
Lymphoproliferaon,
solid organ
autoimmunity,
recurrent infecons.
Enhanced STAT3
signaling, leading to
increased Th17 cell
diﬀerenaon,
lymphoproliferaon
and autoimmunity.
Decreased Tregs and
impaired funcon. Tc
and Bc decreased.
LRBA deﬁciency.
LRBA. AR.
Autoimmune
cytopenias,
enteropathy,
intersal lung
disease, extra-
lymphoid lymphocyc
inﬁltraon, recurrent
infecons. Reduced
IgG and IgA in most.
Low or normal
numbers of Bc.
Normal or decreased
CD4 numbers, Tc
dysregulaon.
BACH2 deﬁciency. BACH2. AD.
Lymphocyc colis,
sinopulmonary infecons.
Impaired memory Bc
development. Progressive Tc
lymphopenia.
Immune Dysregulaon
with Colis:IBD , Nl Tc & Bc
IL-10 deﬁciency. IL10. AR.
Folliculis, recurrent respiratory
diseases, arthris. No funconal IL-
10 secreon.
IL-10Ra deﬁciency. IL10RA AR.
Folliculis, recurrent respiratory
diseases, arthris, lymphoma.
Leukocytes unresponsive to IL-10.
IL-10Rb deﬁciency. IL10RB.AR.
Folliculis, recurrent respiratory
diseases, arthris, lymphoma.
Leukocytes unresponsive to IL10,
IL22, IL26, IL28A, IL28B, IL29
NFAT5 haploinsuﬃciency. NFAT5.
AD. Recurrent Sinopulmonary
infecons. Decreased memory Bc
and plasmablasts.
No Yes
Prolidase deﬁciency. PEPD. AR. Auto-
anbodies common, chronic skin ulcers,
eczema, infecons
Yes Occasionnally
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V. Congenital defects of phagocyte number, funcon, or both. a : Neutropenia( without an-PMN )
No syndrome associatedSyndrome associated
GFI 1 deﬁciency (SCN2). GFI1. AD.
B/T lymphopenia
Elastase deﬁciency (SCN1). ELANE. AD.
Suscepbility to MDS/leukemia. Severe congenital
neutropenia or cyclic neutropenia (perform CBC
twice weekly/ 4 weeks).
HAX1 deﬁciency (Kostmann Disease) (SCN3).
HAX1. AR. Cognive and neurological defects in
paents with defects in both HAX1 isoforms,
suscepbility to MDS/leukemia
G6PC3 deﬁciency (SCN4). G6PC3. AR. Structural heart defects, urogenital abnormalies,
inner ear deafness, and venous angiectasias of trunks and limbs. Aﬀected ns:
Myeloid diﬀerenaon, chemotaxis, O2- producon.
Glycogen storage disease type 1b. G6PT1. AR.
Fasng hypoglycemia, lacc acidosis, hyperlipidemia, hepatomegaly.
VPS45 deﬁciency (SCN5). VPS45. AR.
Extramedullary hematopoiesis, bone marrow ﬁbrosis, nephromegaly.
G-CSF receptor deﬁciency. CSF3R. AR.
Stress granulopoiesis disturbed
P14/LAMTOR2 deﬁciency. LAMTOR2. AR.
Paral albinism, growth failure. Hypogammaglobulinemia, reduced CD8 cytotoxicity.
X-linked neutropenia/ myelodysplasia WAS GOF.
WAS. Myeloid maturaon arrest, monocytopenia,
variable lymphoid anomalies .
Barth Syndrome (3-Methylglutaconic aciduria type II). TAZ. XL.
Cardiomyopathy, myopathy, growth retardaon.
Cohen syndrome. COH1. AR. Dysmorphism, mental retardaon, obesity, deafness.
Clericuzio syndrome (Poikiloderma with neutropenia). C16ORF57 (USB1). AR.
Renopathy, developmental delay, facial dysmorphism, poikiloderma.
JAGN1 deﬁciency. JAGN1. AR. Osteopenia. Myeloid maturaon arrest.
3-Methylglutaconic aciduria. CLPB. AR. Neurocognive developmental aberraons,
microcephaly, hypoglycemia, hypotonia, ataxia, seizures, cataracts, IUGR.
SMARCD2 deﬁciency. SMARCD2. AR.
Developmental aberraons, bones defect, myelodysplasia
Shwachman-Diamond syndrome. SBDS. AR. DNAJC21. AR.
Pancytopenia, exocrine pancreac insuﬃciency, chondrodysplasia
WDR1 deﬁciency. WDR1. AR.
Poor wound healing, severe stomas, neutrophil nuclei herniate. Mild neutropenia.
HYOU1 deﬁciency. HYOU1. AR. Hypoglycemia, inﬂammatory complicaons.
Neutropenia with combined immune deﬁciency.
MKL1. AR.
Mild thrombocytopenia. Lymphopenia.
Rac 2 def . RAC2.                       
Poor wound healing. LAD 
phenotype.
V. Congenital defects of phagocyte. b : Funconal defects
Leukocyte adhesion deﬁciency.
Skin infections evolve to large 
ulcers.  Leukocytosis with 
neutrophilia (WBC > 25000)
LAD I . ITGB2
Delayed cord separation with 
omphalitis+++, no pus formation, 
lack of inflammation is observed in 
infection area. Periodontitis leads 
to early loss of teeth. , CD18 def
(CMF) severity of the disease 
correlates with the degree of 
deficiency in CD18. (WBC 20,000–
150,000 with 60–85 % neutrophils)
LAD II.  SLC35C1
Extremely rare. Recurrent 
infections. Severe growth delay 
and severe intellectual deficit. 
Facial dysmorphism ( depressed 
nasal bridge). Severe periodontitis
later in life. Bombay blood group.  
Infections: rarely life threatening. 
Patients may live to adulthood.
LAD III.   FERMT3
Severe bacterial infections and
severe bleeding disorder; 
osteopetrosis (severe cases). 
Platelet aggregation assay.
Papillon-Lefèvre . CTSC. 
Periodontitis, palmoplantar
hyperkeratosis
β-Actin . ACTB
Mental retardation.
Specific granule deficiency. 
C/EBPE. 
Bilobed nuclei
Localized juvenile
periodontitis . FPR1. 
Periodontitis only
Pulmonary alveolar
proteinosis. CSF2RA, AR.
CSF2RB, XL.
Affected cells: Alveolar
macrophages. Affected fonction: 
GM-CSF signaling
CGD. 
Early onset of severe and
recurrent infections affecting initially 
the natural barriers of  the organism  
( lungs, lymph nodes, skin), and 
eventually inner structures (liver, 
spleen, bones, brain, and +++ 
hepatic abscess). Autoinflammatory
phenotype, IBD
Granulomas obstructing respiratory, 
urinary or gastrointestinal tracts. 
Inflammatory bowel disease (Crohn’s
like disease) and perianal disease : 
up to 30 %
Pathogens : typically catalase
positive bacteria (S. aureus and 
gram-negative bacilli, Aspergillus, 
Candida); other: Burkholderia
cepacia,Chromobacterium
violaceum, Nocardia, and invasive 
Serratia marcescens. In developing 
countries, BCG : adverse effects in 
up to 20 %. Microscopic granulomas.
XL CGD:  CYBB (gp91phox)
NCF1 (p47phox) , AR
CYBA (p22phox), AR 
NCF4 (p40phox), AR
NCF2 (p67phox), AR 
GATA2 def (MonoMac sd) . 
GATA2, AD.
Susceptibility to Mycocbacteria, 
Papilloma Viruses, 
Histoplasmosis, Lymphedema. 
Pulmonary alveolar proteinosis, 
myelodysplasia/AML/ CMML . 
Monocytopenia. Low NK.
Abnormal
Syndrome associated No Syndrome associated:  
DHR  assay (or NBT test)?
Normal
Cystic fibrosis. CFTR. AR. 
Pancreatic insufficiency, 
Respiratory infections, elevated 
sweat chloride
G6PD def Class I. G6PD.
Reduced DHR. Infections.              
Predominant pathogens (S. pneumoniae, S. aureus and
Pseudomonas aeruginosa). Non-invasive bacterial infecons (skin
infecons and upper respiratory tract infecons). Improve with age.
Roune Usual screening tests are normal. Speciﬁc screening tests
(lack of proinﬂammatory cytokine producon and CD62L shedding) :
available only in specialized clinical immunology laboratories.
IRAK4 def . IRAK4, AR
MyD88 def . MYD88, AR.
VI. Defects in Intrinsic and Innate immunity. a : Bacterial and Parasic Infecons
Isolated congenital asplenia.
Bacteremia (encapsulated bacteria). No spleen.
RPSA, AD
HMOX, AR. Hemolysis, nephris, inﬂammaon
Predisposion to Invasive Bacterial infecons
(pyogens):
meningis, sepsis, arthris, osteomyelis and abscesses,
oen in the absence of fever.
IRAK-1 def. IRAK1, XL.
X-linked MECP2 deﬁciency-related syndrome due to a large de novo
Xq28 chromosomal deleon encompassing both MECP2 and IRAK1
Predisposion to Mucocutaneous
Candidiasis (CMC)
Chronic Mucocutaneous
Candidiasis without ectodermal
dysplasia
IL-17RA deﬁciency.
IL17RA, AR
Folliculis. Suscepbility to S.
aureus (skin infecons)
STAT1 GOF. STAT1, AD
various fungal, bacterial and viral
(HSV) infecons, autoimmunity
(thyroidis, diabetes, cytopenias),
enteropathy
CARD9 def. CARD9, AR.
Predisposion to
INVASIVE Fungal
Diseases.
Invasive candidiasis
infecon, deep
dermatophytoses,
other invasive fungal
infecons.
Trypanosomiasis.
APOL1, AD
Inborn Errors of
Immunity Related to
Non-Hematopoiec
Tissues
Predisposion to Parasic and Fungal
infecons
TIRAP def. TIRAP, AR.
Staphylococcal disease during childhood.
ACT1 deﬁciency. ACT1, AR.
Blepharis, folliculis and
macroglossia.
IL-17F deﬁciency.
IL17F, AD. Folliculis.
IL-17RC deﬁciency.
IL17RC, AR.
Others
Osteopetrosis.
TNFRSF11A, PLEKHM1
AR.
TCIRG1, AR. +
hypocalcemia
CLCN7, OSTM1, AR. +
hypocalcemia,
neurologic features
SNX10, AR. + visual
impairment
TNFSF11, AR. + severe
growth retardaon
Hydradenis
suppurava. PSENEN,
AD.
NCSTN, AD. + acne
PSEN, AD. +
hyperpigmentaon
Acute liver failure due
to NBAS def. NBAS, AR.
Fever induces liver
failure
Acute necrozing
encephalopathy.
RANBP2, AD.
Fever induces acute
encephalopathy
Fig. 6 Defects in intrinsic and innate immunity. a Bacterial and parasitic
infections. b MSMD and viral infection. AD: autosomal dominant
transmission; AR: autosomal recessive transmission; BCG: Bacillus
Calmette-Guerin; CD: cluster of differentiation; CMC: chronic
mucocutaneous candidiasis; GOF: gain-of-function; IFNg: interferon-
gamma; HHV6: human herpes virus type 6; HPV: human papilloma
virus; HSV: herpes simplex virus; LOF: loss-of-function; MSMD:
Mendelian susceptibility to mycobacterial disease; NK: natural killer
cells; RNA: ribonucleic acid; sd: syndrome; Tc: T cells; TLR3: Toll-like
receptor type 3; VZV: varicella zoster virus; XL: X-linked transmission
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VI. Defects in Intrinsic and Innate immunity. b : MSMD and Viral infecon
Mendelian Suscepbility to mycobacterial disease
(MSMD)
Severe phenotypes. Moderate phenotypes.
Complete IFNGR1 Def
and IFNGR2 Def.
IFNGR1, IFNGR2. AR.
Serious disseminated
BCG and environmental
mycobacterial infecons
(so	 ssue, bone
marrow, lungs, skin,
bones and lymph nodes),
Salmonella spp., Listeria
monocytogenes and
viruses
With Suscepbility to Salmonella
IL-12 and IL-23 receptor b1 chain deﬁciency.
IL12RB1 .AR.
IL-12p40 (IL-12 and IL-23) def. IL12B .AR.
STAT1 LOF. STAT1(AD)
Paral IFNγR1. IFNGR1. AR.
Paral IFNγR2. IFNGR2.AR.
AD IFNGR1. IFNGR1. AD. Mycobacterial
osteomyelis
Tyk2 deﬁciency. TYK2. AR. Suscepbility to
viruses, +/- elevated IgE. Mulple cytokine
signaling defect.
Dominant clinical
phenotype is Herpes
simplex encephalis (HSE)
during primary infecon
with herpes simplex virus
type 1 (HSV1), usually
between 3 months and 6
years of age. Incomplete
clinical penetrance for all
eologies listed here.
Roune screening tests
are normal.
Speciﬁc tests examining
the TLR3 pathway :
marked decrease in the
ability of paent’s
ﬁbroblasts to produce IFN-
α and β in response to
HSV1 infecon.
TLR3 (AD,AR),
UNC93B1 (AR), TRAF3
(AD), TICAM1 (TRIF)
(AR,AD), TBK1 (AD),
IRF3 (AD).
Predominant suscepbility to viral infecon
Epidermodysplasia
verruciformis (HPV)
EVER1 def.
TMC6.AR.
WHIM (Warts,
Hypogammaglobuline
mia, infecons, myelo-
kathexis) sd.
CXCR4 AD GOF.
Warts (HPV) infecon,
neutropenia, low B cell
number, hypogamma-
globulinemia.
EVER2 def.
TMC8. AR.
Predisposion to
Severe Viral Infecon
STAT1 Def (AR LOF).
STAT1. (+ Mycobacteria)
IRF7 deﬁciency. IRF7. AR.
Severe inﬂuenza disease.
Defect of IFN-α,β and γ
producon and IFN-
producon
STAT2 deﬁciency. STAT2.
AR. Disseminated vaccine-
strain measles
IFNAR2 deﬁciency. IFNAR2
AR. Disseminated vaccine-
strain measles, HHV6. No
response to IFN-α.
CD16 deﬁciency. FCGR3A.
AR. Severe herpes viral
infecons, parcularly VZV,
Epstein Barr virus (EBV),
and HPV.
MDA5 deﬁciency (LOF).
IFIH1. AR. Rhinovirus and
other RNA viruses
Herpes simplex
Encephalis.
ISG15 Def. ISG15. AR. Brain calciﬁcaon. IFNg
producon defect.
Macrophage gp91 phox deﬁciency. CYBB, XL
IRF8 deﬁciency. IRF8 AD
IRF8 deﬁciency. IRF8 AR Mulple other
infecous agents. Myeloproliferaon
RORc deﬁciency. RORC AR. Suscepbility to
Candida. IFNg producon defect, complete
absence of IL-17A/F-producing Tc
JAK1 (LOF). JAK1. AR. Suscepbility to viruses,
urothelial carcinoma. IFNg producon.
Fig. 6 (continued)
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VIIa. Auto-inﬂammatory disorders
OthersRecurrent inﬂammaon
Recurrent fever
Systemic inﬂammaon with urcaria rash
Familial Mediterranean Fever (FMF) *.
MEFV. AR or AD
DA: 1–4 days FA : Variable.
Polyserosis, Abdominal pain, Arthris,
Amyloidosis. Erysipelas-like erythema.
Predisoposes to vasculis and
inﬂammatory bowel disease
Colchicine-responsive +++.
Mevalonate kinase def* (Hyper IgD sd).
MVK. AR
DA: 3–7 days FA: 1–2 monthly.
Cervical adenopathy. Oral aphtosis.
Diarrhea. Mevalonate aciduria during
aacks. Leukocytosis with high IgD levels.
TNF receptor-associated periodic
syndrome; TRAPS. TNFRSF1A. AD.
DA: 1-4 weeks FA : Variable
Prolonged fever. Serosis, rash,
Periorbital edema and conjuncvis;
Amyloidosis. Joint inﬂammaon.
Familial Cold Autoinﬂammatory Syndrome (CAPS) * .
NLRP3, NLRP12. AD GOF DA: 24-48H
Non-pruric urcaria, arthris, chills, fever and leukocytosis a	er
cold exposure.
Muckle Wells syndrome (CAPS) *. NLRP3. AD GOF.
Ethnic group : North European
Connuous fever. O	en worse in the evenings.
Deafness (SNHL), Conjuncvis, Amyloidosis.
Neonatal onset mulsystem inﬂammatory disease (NOMID) or
chronic infanle neurologic cutaneous and arcular syndrome
(CINCA) *. NLRP3. AD GOF.
Neonatal onset rash, with connuous fever and inﬂammaon.
Asepc and chronic meningis, Deforming arthropathy, Mental
retardaon. Sensorineural deafness. Visual loss.
NLRC4-MAS (macrophage
acvang syndrome)*. NLRC4.
AD GOF.
Severe enterocolis and
macrophage acvaon syndrome
(HLH). Triggered by cold
exposure.
PLAID (PLCg2 associated anbody deﬁciency and immune
dysregulaon), or APLAID*. PLC2G. AD GOF.
Cold Urcaria. Autoimmunity. Blistering skin lesion, pulmonary
and bowel disease. Hypogammaglobulinemia, autoinﬂammaon.
NLRP1 deﬁciency*. NLRP1. AR.
Dyskeratosis, autoimmunity and arthris.
CANDLE sd (chronic atypical
neutrophilic dermas with
lipodystrophy).
PSMB8, AR and AD. (Variants in
PSMB4, PSMB9, PSMA3, and
POMP )
Contractures, panniculis, ICC,
fevers.
COPA defect. COPA. AD
Autoimmune inﬂammatory
arthris and intersal lung
disease with Th17 dysregulaon
and autoanbody producon
A20 haploinsuﬃciency. TNFAIP3. AD LOF. Early onset systemic
inﬂammaon, Arthralgia/arthris, oral/genital ulcers, ocular
inﬂammaon.
Fig. 7 a, b Autoinflammatory disorders. *Diseases affecting the
inflammasome. AD: autosomal dominant transmission; AR: autosomal
recessive transmission; BSN: bilateral striatal necrosis; CAPS: cryopirin-
associated periodic syndrome; DA: duration of inflammation episode;
FA: frequency of inflammation episode; FCL: familial chilblain lupus;
GOF: gain-of-function; HLH: hemophagocytic lymphohistiocytosis;
HSM: hepatosplenomegalia; ICC: intracranial calcifications; IL:
interleukin; LOF: loss-of-function; sd: syndrome; SLE: systemic lupus
erythematosus; SMS: Singleton-Merten syndrome; SNHL: sensorineural
hearing loss; SP: spastic paraparesis; TORCH: toxoplasmosis, other,
rubella, cytomegalovirus, and herpes infections
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Sterile inﬂammaon ( skin / bone / joints )
VIIb. Auto-inﬂammatory disorders
CAMPS. CARD14. AD. Psoriasis.
Progressive encephalopathy, ICC, Cerebral atrophy,
HSM, leukodystrophy , Thrombocytopenia, Elevated
hepac transaminases . Chronic cerebrospinal ﬂuid (CSF)
lymphocytosis
Aicardi-Goueres syndrome.
TREX1 AR-AD (+SLE, FCL), RNASEH2A, RNASEH2B (+SP),
RNASEH2C, SAMHD1 (+ Skin vascularis, mouth ulcers,
arthropathy,  FCL), ADAR1 (+BSN, SP), IFIH1 GOF AD (+
SLE, SP, SMS)
Type 1 Interferonopathies
Spondyloenchondro-dysplasia with immune
dysregulaon (SPENCD). ACP5.
Possibly recurrent bacterial and viral infecons, SLE-like
auto-immunity (Sjögren's syndrome, hypothyroidism,
inﬂammatory myosis, Raynaud's disease and viligo),
hemolyc anemia, thrombocytopenia, skeletal dysplasia,
short stature, SP, ICC.
STING-associated vasculopathy, infanle-onset.
TMEM173. Early-onset inﬂammatory disease, Skin
vasculopathy, inﬂammatory lung disease, systemic
autoinﬂammaon and ICC, FCL.
ADA2 deﬁciency. CECR1. Polyarteris nodosa, childhood-
onset, early-onset recurrent ischemic stroke and fever,
Livedo racemosa, low IgM, Hypogammagl, Lymphopenia
XL reculate pigmentary disorder. POLA1. Hyper-
pigmentaon, reculate paern. Inﬂammatory lung and
Gastroenteris or colis. Corneal scarring, characterisc facies
USP18 def . USP18. TORCH like syndrome.
Pyogenic sterile arthris, pyoderma
gangrenosum, acne (PAPA) syndrome,
hyperzincemia and hyper-
calprotecnemia. PSTPIP1 (C2BP1). AD
DA: 5 days FA: Fixed interval : 4-6 weeks
Sterile pyogenic arthris, Pyoderma
gangrenosum, inﬂammatory skin rash,
Myosis. Acute-phase response during
aacks
Chronic recurrent mulfocal osteomyelis
and congenital dyserythropoiec anemia
(Majeed syndrome). LPIN2. AR
DA : Few days FA : 1-3 / month
Chronic recurrent mulfocal osteomyelis,
severe pain, tender so	 ssue swelling,
Transfusion-dependent anemia, cutaneous
inﬂammatory disorders
Blau syndrome. NOD2 (CARD15). AD.
Connuous inﬂammaon.
Uveis, Granulomatous synovis, Camptodactyly,
Rash, Cranial neuropathies, 30% develop Crohn
colis. Sustained modest acute-phase response.
ADAM17 deﬁciency. ADAM17 . AR.
Early-onset pustular dermas, short and broken
hair, paronychia, frequent cutaneous bacterial
infecons, and Early onset diarrhea , high IL-1 and
IL-6 producon. Lack of TNF-α was considered
partly responsible for their increased suscepbility
to infecon and development of cardiomyopathy.
Cherubism. SH3BP2.
AR.
Bone degeneraon in jaws
SLC29A3 mutaon. SLC29A3 . AR.
Hyperpigmentaon hypertrichosis, Rosai-Dorfman
like hisocytosis-lymphadenopathy plus H
syndrome
DITRA. (Deﬁciency of IL-36 receptor antagonist).
IL-36RN. AR .
Life-threatening, mulsystemic inﬂammatory
disease characterized by episodic widespread,
pustular psoriasis, malaise, and leukocytosis.
DIRA (Deﬁciency of the Interleukin 1
Receptor Antagonist). IL1RN. AR
Connuous inﬂammaon.
Neonatal onset of sterile mulfocal
osteomyelis, perioss and pustulosis. Otulipenia/ORAS. OTULIN. AR.
Arthralgia, Fever, diarrhea , dermas.
Lipodystrophy, myalgia, Neutrophilia
Predominant on the skinPredominant on the bone / joints
AP1S3 deﬁciency. AP1S3. AR.
Pustular psoriasis
Fig. 7 (continued)
VIII. Complement deﬁciencies
C9 def. C9.
Mild suscepbility.
Atypical Hemolyc Uremic
Syndrome
Factor D def.
CFD. AR.
C1 inhibitor.
SERPING1.
AD, Hereditary
angioedema.
Spontaneous
acvaon of the
complement pathway
with consumpon of
C4/C2
Properdin
def.
PFC. XL C1s def.C1S.
Mulple autoimmune diseases;
Ehlers Danlos phenotype
SLE-like syndrome.
Infecons with encapsulated
organisms
Absent CH50 hemolyc acvity
C2 def. C2.
Vasculis, Polymyosis,
atherosclerosis
C1q def. C1QA, C1QB, C1QC.
C1r def. C1R. Ehlers Danlos
phenotype
C4 def .C4A, C4B.AR.
Paral deﬁciency is common (either
C4A or C4B) and appears to have a
modest eﬀect on host defense
MASP2 def.
MASP2. AR.
Inﬂammatory lung
disease, autoimmunity
Disseminated
Neisserial infecons
C5 def. C5
C6 def. C6
C7 def . C7.
+ Vasculis
C8 def.
C8A, C8B, C8G
Recurrent
pyogenic
infecons
Membrane Aack
Complex Inhibitor
deﬁciency. CD59.
Hemolyc anemia.
Polyneuropathy.
Ficolin 3 def.
FCN3. AR.
Infecons mainly in
the lungs; abscesses,
necrozing entero-
colis in infancy;
selecve anbody
defect to Pneumo-
coccal polysaccharides.
Absence of
complement acvaon
by the Ficolin 3
pathway
Suscepbility to infecons
High Low
Others
Factor B. CFB LOF.
AR. Infecons with
encapsulated
organisms. Deﬁcient
v n of the
alternave pathway
C3 GOF. C3. AD.
Infecons , glomerulonephris.
Increased acvaon of complementC3 LOF. C3. AR.
Absent CH50 and AH50
hemolyc acvity,
defecve opsonizaon
and humoral response
Factor B GOF. CFB. AD. Increased
spontaneous AH50
Factor H def. CFH. AR or AD.
Infecons, disseminated neisserial
infecons, preeclampsia. Spontaneous
acvaon of the alternave
complement pathway with
consumpon of C3
Thrombomodulin def. THBD.
AD. Normal CH50, AH50
Factor I deﬁciency. AR. Infecons,
disseminated neisserial infecons,
preeclampsia. Spontaneous acvaon
of the alternave complement
pathway with consumpon of C3
Factor H –related protein
deﬁciencies. CFHR1-5. AR or AD.
Later onset, disseminated neisserial
infecons. Normal CH50, AH50,
autoanbodies to Factor H.
Membrane Cofactor Protein
deﬁciency. CD46.AD,Glomerulone-
phris. Infecons, preeclampsia .
Inhibitor of complement alternate
pathway, decreased C3b binding
Absent CH50 and AH50
hemolyc acvity.
Defecve bactericidal
acvity.
Normal CH50.
Absent AH50
hemolyc
acvity
CD55 deﬁciency
(CHAPLE disease).
CD55. AR. Protein
losing enteropathy,
thrombosis
Fig. 8 Complement deficiencies. AD: autosomal dominant transmission;
AH50: alternate pathway hemolytic activity; AR: autosomal recessive
transmission; CH50: complement hemolytic activity; def: deficiency;
LOF: loss-of-function; sd: syndrome; SLE: systemic lupus
erythematosus; XL: X-linked transmission
IX. Phenocopies of PID
Splenomegaly, lymphadenopathy,                                   
autoimmune cytopenias. Defecve lymphocyte apoptosis. 
ALPS-SFAS.
(somac mutaons in TNFRSF6)/ ALPS-FAS  (ALPS type Im)
RALD. RAS-associated autoimmune leukoproliferave
disease. (ALPS Like); N-RAS GOF, K-RAS GOF
Sporadic; granulocytosis, monocytosis/ALPS-like
Associated with 
Somatic Mutations
Recurrent skin infecon. AutoAb to IL-6.
Staphylococcal infecons   /  STAT3 deﬁciency
Adult-onset immunodeﬁciency with suscepbility to mycobacteria. 
Auto-Ab to IFNg. 
Mycobacterial, fungal, salmonella, VZV infecons   /  MSMD or CID. 
Associated with 
Auto-Antibodies
Chronic mucocutaneous candidiasis (isolated or with APECED 
syndrome). AutoAb to IL-17 and/or IL-22. 
Endocrinopathy, chronic mucocutaneous candidiasis /CMC. 
Germline mutaon in AIRE
Pulmonary alveolar proteinosis . AutoAb to GM-CSF.
Pulmonary alveolar proteinosis, cryptococcal meningis, 
disseminated nocardiosis/CSF2RA deﬁciency 
Acquired angiooedema . AutoAb to C1 inhibitor. 
Angioedema /C1 inhibitor deﬁciency
Cryopyrinopathy, (Muckle-Wells /CINCA/NOMID-like 
syndrome). NRLP3.
Urcaria-like rash, arthropathy, neurological symptoms
Atypical Hemolyc Uremic Syndrome . AutoAb to Factor H. 
Spontaneous acvaon of the alternave complement pathway
Hypereosinophilic syndrome due to somac mutaons in 
STAT5b. STAT5b. GOF. 
Atopic dermas, urcarial rash, diarrhea. Eosinophilia.
Thymoma with hypogammaglobulinemia (Good syndrome). 
AutoAb to various cytokines. Invasive bacterial, viral or 
opportunisc infecons, autoimmunity, PRCA, lichen planus, 
cytopenia, colis, chronic diarrhea. No B cells. 
Fig. 9 Phenocopies of PID.
ALPS: autoimmune
lymphoproliferative syndrome;
AutoAb: auto-antibodies; CID:
combined immunodeficiency;
CMC: chronic mucocutaneous
candidiasis; GOF: gain-of-
function; MSMD: Mendelian
susceptibility to mycobacterial
disease; PRCA: pure red cell
aplasia
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